209 related articles for article (PubMed ID: 26142359)
1. The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.
Kratzer J; Cheng L; Allin S; Law MR
Healthc Policy; 2015 May; 10(4):62-74. PubMed ID: 26142359
[TBL] [Abstract][Full Text] [Related]
2. Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.
McLeod L; Bereza BG; Shim M; Grootendorst P
Open Med; 2011; 5(1):e1-9. PubMed ID: 22046212
[TBL] [Abstract][Full Text] [Related]
3. How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?
Allin S; Law MR; Laporte A
Health Policy; 2013 May; 110(2-3):147-55. PubMed ID: 23522381
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Affordable Care Act's young adult insurance expansion on prescription drug insurance coverage, utilization, and expenditures.
Look KA; Arora P
Res Social Adm Pharm; 2016; 12(5):682-98. PubMed ID: 26632980
[TBL] [Abstract][Full Text] [Related]
5. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
Kennedy J; Morgan S
Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
[TBL] [Abstract][Full Text] [Related]
6. Disparities in prescription drug insurance coverage.
Millar WJ
Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
[TBL] [Abstract][Full Text] [Related]
7. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
8. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries.
Morgan SG; Lee A
BMJ Open; 2017 Jan; 7(1):e014287. PubMed ID: 28143838
[TBL] [Abstract][Full Text] [Related]
9. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
Mulvale G; Hurley J
J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
[TBL] [Abstract][Full Text] [Related]
10. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic differences in prescription drug supplemental coverage in Canada: A repeated cross-sectional study.
Guo EX; Sweetman A; Guindon GE
Health Policy; 2020 Mar; 124(3):252-260. PubMed ID: 31952864
[TBL] [Abstract][Full Text] [Related]
12. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015.
Tang W; Xie J; Kong F; Malone DC
Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927
[TBL] [Abstract][Full Text] [Related]
13. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
Morgan SG; Li W; Yau B; Persaud N
CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
[TBL] [Abstract][Full Text] [Related]
14. A pilot study on cost-related medication nonadherence in Ontario.
Zheng B; Poulose A; Fulford M; Holbrook A
J Popul Ther Clin Pharmacol; 2012; 19(2):e239-47. PubMed ID: 22805096
[TBL] [Abstract][Full Text] [Related]
15. Impact of health reform on young adult prescription medication utilization.
Pakyz A; Wang H; Cunningham P
Am J Manag Care; 2017 Nov; 23(11):670-676. PubMed ID: 29182353
[TBL] [Abstract][Full Text] [Related]
16. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses.
Rodbard HW; Green AJ; Fox KM; Grandy S;
Diabetes Res Clin Pract; 2010 Mar; 87(3):360-5. PubMed ID: 20047768
[TBL] [Abstract][Full Text] [Related]
17. Strategies used by adults to reduce their prescription drug costs.
Cohen RA; Kirzinger WK; Gindi RM
NCHS Data Brief; 2013 Apr; (119):1-8. PubMed ID: 23742848
[TBL] [Abstract][Full Text] [Related]
18. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation.
Sullivan PW; Campbell JD; Ghushchyan VH; Globe G; Lange J; Woolley JM
J Asthma; 2015 Sep; 52(7):669-80. PubMed ID: 25731600
[TBL] [Abstract][Full Text] [Related]
20. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
